Westmead Millennium Institute logo  

 

 

arc

Latest News

Australia Day Honour

Westmead Millennium Institute, Director, Professor Anthony Cunningham,  has been awarded an Order of Australia (AO) in the Australia Day Honours List. Click here for more information (PDF, 52Kb).

 

WMI Annual Report

The latest WMI Annual Report is now available.Cancer cells

Click here for more information.

 

NHMRC and ARC project grants boost Westmead Millennium Institute research activities

Click here for further information on the NHMRC and ARC project grants announced in November 2009 that will boost WMI research activities.

 

WMI Researchers receive NHMRC Enabling Grants

ovarian cancer cellsWMI Researchers are part of the teams to receive NHMRC Enabling Grants over the next five years which will assist with the Australiasian Biospecimen Network and Breast Cancer Biospecimen Resource. Click here for more information.

 

Gene variant provides clue to treating hepatitis C

Hepatitis C

Westmead Millennium Institute scientists led international team of medical researchers to identify a variant in the interferon gene IL28B, linking it with the treatment of chronic hepatitis C virus. Study results now online at Nature Genetics. Click here for more information (PDF).

 

Westmead Millennium Institute Awards 2009

NSW Minister for Science and Medical Research, the Hon. Jodi McKay recently presented the Westmead Millennium Institute Sciences Prizes and the Westmead Medical Research Foundation Top-up grants for 2009. The grants totalling over $275,000 support the research work of more than 40 PhD students and scientists based at WMI. Click here for more information.

 

The Move Movement

The Move MovementThe Move Movement is a healthy active lifestyle initiative from the Westmead Medical Research Foundation. You set the challenge, then swim, ride, walk and run your way to health and fitness while raising funds for charity.

 

Links

Search this site

The Westmead Millennium Institute is one of the largest medical research institutes in Australia with over 420 staff conducting research into a wide range of important human disorders affecting both adults and children. Our research spans:

  • infectious and immune diseases

  • cancer and leukaemia

  • liver and metabolic diseases

  • eye and brain-related disorders

  • heart and respiratory disorders.

Closely affiliated with both Westmead Hospital and the University of Sydney, our research extends from the laboratory to the patient, using the basic tools of molecular and cell biology, genetic epidemiology, imaging technology and clinical research. This ‘Bench to Bedside’ approach enables greater translation of research from biomedical discovery to the development of new prevention strategies, diagnostics and more effective treatments.

Research in focus

Dr Wayne Hawthorne

Wayne Hawthorne is Senior Research Fellow in Surgery within the faculty of Medicine at the University of Sydney. He is also Director of National Pancreas and Islet Transplant Laboratories at Westmead Hospital.

 

Dr Hawthorne's main research interest is in clinical islet transplantation and is the director of the islet isolation core for the JDRF/NH&MRC program grant for the Australian wide islet transplantation consortium. The aim of which is the development of pancreatic islet transplantation as a mainstream therapy for patients with difficult to control Type 1 diabetes.

 

His laboratory research is focused primarily on the surgical models used for assessment of immunobiology of islet xenograft rejection and developing islet xenografts as a clinical therapy. His major focus rests on the joint NHMRC/JDRF program grant that is devoted to the development of pig islets as treatment for patients suffering from Type 1 diabetes.

 

He has long-standing collaborations with researchers within Australia at, St Vincent's Hospital Melbourne, Walter and Eliza Hall Institute, The Garvan Institute, Adelaide University, The Children's Hospital at Westmead and overseas at the Diabetes Institute for Immunology and Transplantation, Minneapolis University, Minneapolis, USA, Edmonton Clinical Islet Transplant Unit, Edmonton, Canada, National Human Stem Cells Research Engineering Center of the Hunan Province and the Cell Transplantation and Gene Therapy Research Centers of China.

 

Dr Anna deFazioAnna deFazio is Senior Clinical Lecturer, Department of Obstetrics and Gynaecology, University of Sydney and the Head of the Gynaecological Oncology Research Group, Westmead Institute for Cancer Research at Westmead Hospital.

She embarked on postdoctoral studies at the Garvan Institute of Medical Research in Sydney (1988-1995) and moved to the Department of Gynaecological Oncology at Westmead Hospital in 1995. Dr deFazio was appointed a Senior Clinical Lecturer of the University of Sydney in 1999.

 

Dr deFazio has a long-standing commitment to translational research with an emphasis on gynaecological malignancies. Her research program is focused on improving treatment outcome, particularly for women with ovarian cancer, and on identifying factors that modify risk of developing cancer.

 

She works with a team of postdoctoral researchers, postgraduate students, research assistants and clinical colleagues, and has active collaborations with other local, national and international research groups. The group is supported by national and international peer-reviewed grants.

 

 

PDF icon

Click here to view the Ovarian Cancer Fact Sheet (PDF, 139Kb).

 

 

 

WMI arcs and links Link to The University of Sydney Breast Cancer Tissue Bank Core Technology Platforms PhD Opportunities

 

 


| Home | About Us | Research | Our People | Westmead Medical Research Foundation | News & Events | Contact Us | Search |

 


© 2000-2008 Westmead Millennium Institute